CTRI/2023/12/060586Not yet recruitingPhase 3
assessment of vasadi kwath in vatrakta (gout)- a randomised controlled clinical trial - nil
DR GHULE SHUBHAM0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •SR URIC ACID >7MG/DL FOR MEN
- •SR URIC ACID >6MG/DL FOR WOMEN
- •CHRONIC CASES OF GOUT
Exclusion Criteria
- •IMMUNOCOMPROMISED PATIENTS OR PATIENTS ON IMMUNOSUPPRESSIVE DRUGS
- •PATIENTS SUFFERING FROM LIFE THREATENING DISEASE
- •PREGNANT WOMEN AND LACTATING MOTHER
- •PATIENTS WITH CHRONIC KIDNEY DISEASE AND END STAGE RENAL DISEASE AND REQUIRING DIALYSIS
- •PATIENTS TAKING DIURETICS ASPIRIN ETHAMBUTOL PYRIZINAMIDE CYCLOSPORINE CYTOTOXIC DRUGS
Investigators
Similar Trials
Completed
Phase 3
To evaluate the efficacy of Vatsadani Kwath in the treatment of Vatrakta (Gout)CTRI/2023/04/051350DEPARTMENT OF KAYACHIKITSA COLLEGE OF AYURVED BHARTI VIDYAPEETH DEEMED TO BE UNIVERSITY30
Unknown
Phase 2
Kwath in gout (increased uric acid)CTRI/2020/04/024821Archana arya36
Not yet recruiting
Unknown
study of vyoshadi gutika in vataja pratishyaya (allergic rhinitis)CTRI/2023/07/054777Rishikul Campus
Not yet recruiting
Not Applicable
Ayurvedic management for goutCTRI/2019/07/019972Dr Rukhsar Sheikh
Not yet recruiting
Phase 2
Effect of vachadi kwatha & lekhana basti in Medoroga(Dyslipidemia)CTRI/2024/05/067312Dr. Anjali Kanojia